↓ Skip to main content

Propolis Extract for Onychomycosis Topical Treatment: From Bench to Clinic

Overview of attention for article published in Frontiers in Microbiology, April 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
98 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Propolis Extract for Onychomycosis Topical Treatment: From Bench to Clinic
Published in
Frontiers in Microbiology, April 2018
DOI 10.3389/fmicb.2018.00779
Pubmed ID
Authors

Flavia F. Veiga, Marina C. Gadelha, Marielen R. T. da Silva, Maiara I. Costa, Brenda Kischkel, Lidiane V. de Castro-Hoshino, Francielle Sato, Mauro L. Baesso, Morgana F. Voidaleski, Vanessa Vasconcellos-Pontello, Vânia A. Vicente, Marcos L. Bruschi, Melyssa Negri, Terezinha I. E. Svidzinski

Abstract

Onychomycosis is a chronic fungal infection of nails, commonly caused by dermatophyte fungi, primarily species of Trichophyton. Because of the limited drug arsenal available to treat general fungal infections and the frequent failure of onychomycosis treatment, the search for new therapeutic sources is essential, and topical treatment with natural products for onychomycosis has been encouraged. Propolis, an adhesive resinous compound produced by honeybees (Apis mellifera), has shown multiple biological properties including significant antifungal and anti-biofilm activities in vitro. In spite of promising in vitro results, in vivo results have not been reported so far. This study assessed an ethanol propolis extract (PE) as a topical therapeutic option for onychomycosis, including its characterization in vitro and its applicability as a treatment for onychomycosis (from bench to clinic). The in vitro evaluation included analysis of the cytotoxicity and the antifungal activity against the planktonic cells and biofilm formed by Trichophyton spp. We also evaluated the capacity of PE to penetrate human nails. Patients with onychomycosis received topical PE treatments, with a 6-month follow-up period. The results of the in vitro assays showed that PE was non-toxic to the cell lines tested, and efficient against both the planktonic cells and the biofilm formed by Trichophyton spp. The results also showed that PE is able to penetrate the human nail. The results for PE applied topically to treat onychomycosis were promising, with complete mycological and clinical cure of onychomycosis in 56.25% of the patients. PE is an inexpensive commercially available option, easy to obtain and monitor. Our results indicated that PE is a promising natural compound for onychomycosis treatment, due to its ability to penetrate the nail without cytotoxicity, and its good antifungal performance against species such as Trichophyton spp. that are resistant to conventional antifungals, both in vitro and in patients.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 98 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 13%
Student > Master 11 11%
Student > Ph. D. Student 9 9%
Researcher 7 7%
Professor 5 5%
Other 13 13%
Unknown 40 41%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 16 16%
Biochemistry, Genetics and Molecular Biology 8 8%
Medicine and Dentistry 7 7%
Chemistry 7 7%
Nursing and Health Professions 4 4%
Other 14 14%
Unknown 42 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 June 2020.
All research outputs
#2,817,629
of 23,090,520 outputs
Outputs from Frontiers in Microbiology
#2,451
of 25,257 outputs
Outputs of similar age
#59,946
of 326,620 outputs
Outputs of similar age from Frontiers in Microbiology
#93
of 612 outputs
Altmetric has tracked 23,090,520 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 25,257 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 326,620 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 612 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.